A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102
- Citation:
- Support Care Cancer vol 29 (1) 387-96
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 2972
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- UG1CA189823; U24CA196171, UG1CA232760; UG1CA189858, UG1CA189997; U10CA180820, UG1CA189861 (ECOG-ACRIN); U10CA180868 (NRG)
- Corr. Author:
- Authors:
- Elizabeth Cathcart-Rake Paul Novotny Roberto Leon-Ferre Jennifer Le-Rademacher Elizabeth M. Storrick Araba A. Adjei Shelby Terstriep Rebecca Glaser Armando Giuliano William R. Mitchell Seth Page Colleen Austin Richard L. Deming Margaret A. Ferreira Jacqueline M. Lafky Stephen N. Birrell Charles L. Loprinzi
- Networks:
- CA016, DAYTON, IWORC, KS055, LAPS-MN026, SANFORD, SCOR
- Study
- Alliance-A221102
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: